ClinicalTrials.gg
Sign In
Status unknownNCT06802497Updated Jan 31, 2025

Comparison of Postoperative Outcomes of Laparoscopic Lateral Suspension and V-NOTES Lateral Suspension With the Salman Ketenci Gencer Technique

An observational study in Pelvic Organ Prolapse, sponsored by Gaziosmanpasa Research and Education Hospital. Status unknown at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-01-31.

Sponsored by Gaziosmanpasa Research and Education Hospital · Observational

The sponsor has not verified this record recently (last verified Jul 2024), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
84
Ages
18 Years to 75 Years
Sex
Female
01

Study summary

Comparison of Early Postoperative Outcomes of Patients Undergoing Laparoscopic Lateral Suspension and V-NOTES Lateral Suspension with the Salman Ketenci Gencer Technique

02

Conditions studied

  • Pelvic Organ Prolapse

Browse trials for

Keywords

  • laparoscopy
  • v-notes lateral suspension
  • pelvic organ prolapse
03

In context

Pelvic Organ Prolapse

516 studies on the registry are indexed under Pelvic Organ Prolapse; 80 are open to participants now.

This study's planned enrollment of 84 is below the median of 131 across 168 observational studies indexed under Pelvic Organ Prolapse.

Browse Pelvic Organ Prolapse studies →

Lead sponsor

Gaziosmanpasa Research and Education Hospital is the lead sponsor of 125 studies on the registry; 29 are open to participants now.

Browse Gaziosmanpasa Research and Education Hospital studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study planned to include 84 patients with pelvic organ prolapse.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with stage 3 or 4 pelvic organ prolapse Sexually active patients

Exclusion criteria

Exclusion Criteria:

  • Cervical pathology History of loop electrosurgical excision procedure (LEEP) or conization Presence of vaginal, pelvic, or adnexal mass Suspicious abdominal malignancy Morbid obesity Any pelvic infection Signs of pregnancy
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
84 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients underwent laparoscopic lateral suspension
  • patients underwent V-NOTES lateral suspension with SalmanKetenciGencer technique
06

What researchers measure

Primary outcomes

  1. Postoperative Improvement in Pelvic Organ Prolapse (POP) Severity by POP-Q Score

    POP-Q measurements assess the degree of pelvic organ prolapse in patients, using a combined system that includes multiple parameters to evaluate the anterior and posterior vaginal walls, cervix, and vaginal vault. This study will compare the POP-Q values of patients following laparoscopic lateral suspension and V-Notes lateral suspension with the Salmanketencigencer technique to assess improvements in prolapse severity.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Gaziosmanpaşa Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2024 (actual). Primary completion is estimated for Jun 2025, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 4, 2025
First posted
Jan 31, 2025
StartActual
Jul 12, 2024
Primary completionEst.
Jun 1, 2025
CompletionEst.
Dec 1, 2025
Last update
Jan 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06802497
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Responsible party
Sponsor
First posted
Jan 31, 2025
Start date
Jul 12, 2024
Primary completion
Jun 1, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Jan 31, 2025

Study contacts

Fatma Ketenci Gencer, Associate Professor
Contact
fathma_k@hotmail.com
+905416116469
Havva Betül Bacak, Specialist
Contact
hbbacak90@gmail.com
+905333610088

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pelvic Organ Prolapse →

Other studies from this sponsor

Gaziosmanpasa Research and Education Hospital →

Start the discussion